TECLens


TECLens is dedicated to transforming the future of vision care through innovative, non-invasive, personalized corneal cross-linking treatments utilizing proprietary qCXL™ technology. Their mission is to improve vision outcomes, accessibility, and patient experience worldwide, aiming to redefine vision correction with breakthrough solutions that enhance quality of life.

Industries

health-care
medical-device

Nr. of Employees

small (1-50)

TECLens

New York, New York, United States, North America


Products

Integrated corneal cross‑linking system (multi‑component)

A treatment system composed of a single‑use therapy delivery component that provides UV therapy and enables ultrasound monitoring, a control console that houses control electronics and monitoring hardware, a photoactive therapeutic agent, and a computational treatment planning suite to personalize procedures.


Services

Clinical investigator engagement and trial site recruitment

Engagement and onboarding of ophthalmology investigators and clinical sites for pilot and clinical studies.

Device development and system integration

End‑to‑end engineering for integration of disposable therapy delivery components with control consoles and monitoring systems.

Prototype assembly and small‑batch production

Bench assembly, PCB handling, soldering, adhesives dispensing and 3D printing for prototype and low‑volume product builds.

Expertise Areas

  • Refractive ophthalmic device development
  • Photochemical ophthalmic therapy development
  • Medical device system integration
  • Treatment planning software for ophthalmic procedures
  • Show More (4)

Key Technologies

  • Ultraviolet (UV) therapeutic delivery
  • Real‑time ultrasound monitoring
  • Computational treatment planning (TPS)
  • Photoactive therapeutic agents (photochemistry)
  • Show More (4)

Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.